Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents
Dushyant V. Patel, Nirav R. Patel, Ashish M. Kanhed, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 8, pp. 3635-3661
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
Divya Teli, Mamta B. Shah, Mahesh T. Chhabria
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 126
Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations
Samuele Maramai, Mohamed Benchekroun, Moustafa T. Gabr, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-27
Open Access | Times Cited: 88
Unique Carbazole-Oxadiazole Derivatives as New Potential Antibiotics for Combating Gram-Positive and -Negative Bacteria
Yun‐Peng Xie, Sangaraiah Nagarajan, Jiang Ping Meng, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 8, pp. 6171-6190
Closed Access | Times Cited: 55
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Elisabet Viayna, Nicolas Coquelle, Monika Cieslikiewicz‐Bouet, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 812-839
Open Access | Times Cited: 65
Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies
Devendra Kumar, Sahil Sharma, Sourav Kalra, et al.
Current Drug Targets (2020) Vol. 21, Iss. 9, pp. 864-891
Closed Access | Times Cited: 58
Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer’s disease
Yash Pal Singh, Gullanki Naga Venkata Charan Tej, Amruta Pandey, et al.
European Journal of Medicinal Chemistry (2020) Vol. 198, pp. 112257-112257
Closed Access | Times Cited: 53
Pivotal role of nitrogen heterocycles in Alzheimer’s disease drug discovery
Shikha Kumari, Maddeboina Krishnaiah, Rinda Devi Bachu, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103322-103322
Open Access | Times Cited: 35
Design, Synthesis and Exploration of Novel Triazinoindoles as Potent Quorum-Sensing Inhibitors and Radical Quenchers
Jyoti Rasgania, Renu Gavadia, N.P. Sahu, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 5, pp. 399-416
Closed Access | Times Cited: 5
Design, synthesis, biological evaluation, and in silico studies of imidazo[2,1-b][1,3,4]thiadiazole derivatives as cholinesterase inhibitors
Wen-Rong Du, Yixuan Wang, Xue-Wei Zhou, et al.
Medicinal Chemistry Research (2025)
Closed Access
Design, Synthesis, and Pharmacological Evaluation of Embelin–Aryl/alkyl Amine Hybrids as Orally Bioavailable Blood–Brain Barrier Permeable Multitargeted Agents with Therapeutic Potential in Alzheimer’s Disease: Discovery of SB-1448
Vijay K. Nuthakki, Sushil Choudhary, Chilakala Nagarjuna Reddy, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 6, pp. 1193-1219
Closed Access | Times Cited: 12
Novel carbazole-stilbene hybrids as multifunctional anti-Alzheimer agents
Dushyant V. Patel, Nirav R. Patel, Ashish M. Kanhed, et al.
Bioorganic Chemistry (2020) Vol. 101, pp. 103977-103977
Closed Access | Times Cited: 34
Promising heterocycle-based scaffolds in recent (2019–2021) anti-Alzheimer's drug design and discovery
Atukuri Dorababu
European Journal of Pharmacology (2022) Vol. 920, pp. 174847-174847
Closed Access | Times Cited: 21
Development of novel 9H-carbazole-4H-chromene hybrids as dual cholinesterase inhibitors for the treatment of Alzheimer’s disease
Nissi Sharon, Vinod G. Ugale, Pannala Padmaja, et al.
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 379-396
Closed Access | Times Cited: 3
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
F. Javier Pérez-Areales, María Garrido, Ester Aso, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 17, pp. 9360-9390
Open Access | Times Cited: 31
Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer’s disease
Yash Pal Singh, Gauri Shankar, Shagufta Jahan, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116385-116385
Closed Access | Times Cited: 24
Tryptamine: A privileged scaffold for the management of Alzheimer's disease
Yash Pal Singh, Harish Kumar
Drug Development Research (2023) Vol. 84, Iss. 8, pp. 1578-1594
Closed Access | Times Cited: 9
Further Studies on Triazinoindoles as Potential Novel Multitarget-Directed Anti-Alzheimer’s Agents
Dushyant V. Patel, Nirav R. Patel, Ashish M. Kanhed, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 21, pp. 3557-3574
Closed Access | Times Cited: 23
Discovery of novel thiophene-3-carboxamide derivatives as potential VEGFR-2 inhibitors with anti-angiogenic properties
Tai Li, Jiawei Wang, Limiao Feng, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107358-107358
Closed Access | Times Cited: 2
Indoloquinoxaline derivatives as promising multi-functional anti-Alzheimer agents
Ashish M. Kanhed, Dushyant V. Patel, Nirav R. Patel, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 6, pp. 2498-2515
Closed Access | Times Cited: 17
Progress and Development of Carbazole Scaffold Based as Potential Anti- Alzheimer Agents Using MTDL Approach
Nitin Kumar, Pankaj Gupta, Sahil Bansal
Letters in Drug Design & Discovery (2022) Vol. 19, Iss. 12, pp. 1049-1067
Closed Access | Times Cited: 10
Novel alkyl-substituted 4-methoxy benzaldehyde thiosemicarbazones: Multi-target directed ligands for the treatment of Alzheimer's disease
Mokshada E. Varma, Vinod G. Ugale, Javeria Shaukat, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 176028-176028
Closed Access | Times Cited: 5
Design, Synthesis, and Biological Evaluation of 1,2,3-Triazole-linked triazino[5,6-b]indole-benzene sulfonamide Conjugates as Potent Carbonic Anhydrase I, II, IX, and XIII Inhibitors
Krishna Kartheek Chinchilli, Andrea Angeli, Pavitra S. Thacker, et al.
Metabolites (2020) Vol. 10, Iss. 5, pp. 200-200
Open Access | Times Cited: 14
Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer’s Disease
Lilesh Kumar Pradhan, Pradyumna Kumar Sahoo, Santosh Chauhan, et al.
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 6, pp. 1143-1165
Closed Access | Times Cited: 9
Design, Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer’s disease
Harish Kumar, Anju Goyal, Navneet Kumar, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 11, pp. 1931-1947
Closed Access | Times Cited: 9
Design, Synthesis and Biological Evaluation of Novel 6‐Amino‐3‐phenyl‐2H‐chromen‐2‐one Derivatives for Polycystic Ovary Syndrome Management
S. Khan, Bhanubhai N. Suhagia, Navnit Prajapati, et al.
ChemistrySelect (2024) Vol. 9, Iss. 38
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top